278 related articles for article (PubMed ID: 29348469)
1. Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation.
Lambers C; Roth M; Jaksch P; Muraközy G; Tamm M; Klepetko W; Ghanim B; Zhao F
Sci Rep; 2018 Jan; 8(1):1087. PubMed ID: 29348469
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.
Lambers C; Kornauth C; Oberndorfer F; Boehm PM; Tamm M; Klepetko W; Roth M
PLoS One; 2018; 13(11):e0205195. PubMed ID: 30383775
[TBL] [Abstract][Full Text] [Related]
3. IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but Can Be Inhibited by Treprostinil through DUSP1.
Blumer S; Fang L; Chen WC; Khan P; Hostettler K; Tamm M; Roth M; Lambers C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831059
[TBL] [Abstract][Full Text] [Related]
4. Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis.
Lambers C; Boehm PM; Karabacak Y; Samaha E; Benazzo A; Jaksch P; Roth M
Biomed Res Int; 2019; 2019():1345402. PubMed ID: 30984775
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
Rønnow SR; Dabbagh RQ; Genovese F; Nanthakumar CB; Barrett VJ; Good RB; Brockbank S; Cruwys S; Jessen H; Sorensen GL; Karsdal MA; Leeming DJ; Sand JMB
Respir Res; 2020 May; 21(1):108. PubMed ID: 32381012
[TBL] [Abstract][Full Text] [Related]
6. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation.
Esnault S; Torr EE; Bernau K; Johansson MW; Kelly EA; Sandbo N; Jarjour NN
PLoS One; 2017; 12(1):e0170207. PubMed ID: 28095470
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Joannes A; Morzadec C; Duclos M; Gutierrez FL; Chiforeanu DC; Le Naoures C; De Latour B; Rouzé S; Wollin L; Jouneau S; Vernhet L
Toxicol Appl Pharmacol; 2022 Apr; 441():115972. PubMed ID: 35276128
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
[TBL] [Abstract][Full Text] [Related]
15. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.
Szóstek-Mioduchowska AZ; Lukasik K; Skarzynski DJ; Okuda K
Theriogenology; 2019 Jan; 124():9-17. PubMed ID: 30321755
[TBL] [Abstract][Full Text] [Related]
16. Treprostinil Reconstitutes Mitochondrial Organisation and Structure in Idiopathic Pulmonary Fibrosis Cells.
Fang L; Chen WC; Jaksch P; Molino A; Saglia A; Roth M; Lambers C
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569523
[TBL] [Abstract][Full Text] [Related]
17. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
18. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
[TBL] [Abstract][Full Text] [Related]
20. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts.
Goulet S; Bihl MP; Gambazzi F; Tamm M; Roth M
J Cell Physiol; 2007 Jan; 210(1):167-76. PubMed ID: 17013807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
